{"id":"W6902119880","doi":"10.6084/m9.figshare.19556169","title":"Additional file 1 of Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Monoclonal antibody; Protocol (science); Clinical trial; Antibody; Phases of clinical research; Transplantation; Informed consent","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004044455,0.001048429,0.001660422,0.0008089145,0.0008002738,0.001088261,0.001144502,0.00140912,0.7848483],"category_scores_gemma":[0.02595818,0.0006498654,0.001097286,0.001441202,0.0003539837,0.001404346,0.0005243091,0.001378445,0.07592137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001264076,"about_ca_system_score_gemma":0.002595488,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001731501,"about_ca_topic_score_gemma":0.004519541,"domain_scores_codex":[0.9986206,0.000529856,0.0002959472,0.0001772424,0.0002381386,0.0001382945],"domain_scores_gemma":[0.9798007,0.01338575,0.002770768,0.001269495,0.002184776,0.0005885304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01710386,0.0009419464,0.001127008,0.01071924,0.0003032653,0.00009533487,0.00008190885,0.0005669384,0.0003008447,0.001752531,0.9321194,0.03488767],"study_design_scores_gemma":[0.2579986,0.007797786,0.02435742,0.01041551,0.001438178,0.0009704574,0.000181846,0.002914866,0.001902999,0.01437457,0.6774521,0.0001955983],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"protocol","genre_scores_codex":[0.001724596,0.0003875495,0.001303703,0.0009308737,0.0001529132,0.01155344,0.9745018,0.0004980166,0.008947179],"genre_scores_gemma":[0.06755808,0.002108316,0.01896526,0.006131947,0.0009717447,0.1795305,0.6544498,0.0009361827,0.06934825],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.7848483,"threshold_uncertainty_score":0.3068877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05515358387017075,"score_gpt":0.3940226603364138,"score_spread":0.338869076466243,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}